12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Ipsen, PeptiDream deal

The companies partnered to discover and develop therapeutic peptides to treat indications of interest to Ipsen, including neurology, endocrinology and oncology. The partners will use PeptiDream's Peptide Discovery Platform...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >